De novo expression of transfected sirtuin 3 enhances susceptibility of human MCF-7 breast cancer cells to hyperoxia treatment

Free Radical Research

Volumn 52, Issue 6, 2018, Pages 672-684

  Pinterić, Marija ^a   Podgorski, Iva I ^a   Sobočanec, Sandra ^a   Popović Hadžija, Marijana ^a   Paradžik, Mladen ^a   Dekanić, Ana ^a   Marinović, Maja ^a   Halasz, Mirna ^a   Belužić, Robert ^a   Davidović, Grazia ^a   Ambriović Ristov, Andreja ^a   Balog, Tihomir ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Hyperoxia; MCF 7; mitochondrial function; ROS; sirtuin 3

Indexed keywords

PROTEIN P53; SIRTUIN 3; CATALASE; OXYGEN; REACTIVE OXYGEN METABOLITE; SIRT3 PROTEIN, HUMAN; SNAI1 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR SNAIL; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VEGFA PROTEIN, HUMAN; VIMENTIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL AGING; CELL CLONING; CELL GROWTH; CELL SURVIVAL; DNA DAMAGE; EPITHELIAL MESENCHYMAL TRANSITION; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPEROXIA; MCF-7 CELL LINE; METABOLISM; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; UPREGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; SIGNAL TRANSDUCTION; TRANSGENE;

CATALASE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; MCF-7 CELLS; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; OXYGEN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SIRTUIN 3; SNAIL FAMILY TRANSCRIPTION FACTORS; SUPEROXIDE DISMUTASE; TRANSFECTION; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VIMENTIN;

EID: 85045836577     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715762.2018.1462495     Document Type: Article

References (39)

1. Giralt A, Villarroya F., SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J. 2012;444(1):1–10.
2. Schwer B, North BJ, Frye RA, et al. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol. 2002;158(4):647–657.
3. Brown K, Xie S, Qiu X, et al. SIRT3 reverses aging-associated degeneration. Cell Rep. 2013;3(2):319–327.
4. Torrens-Mas M, Oliver J, Roca P, et al. SIRT3: oncogene and tumor suppressor in cancer. Cancers (Basel). 2017;9(7):90.
5. Yu L, Chen X, Wang L, et al. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget. 2016;7(25):38908–38926.
6. Kalliomäki T, Hill RP., Effects of tumour acidification with glucose + MIBG on the spontaneous metastatic potential of two murine cell lines. Br J Cancer. 2004;90(9):1842–1849.
7. Moen I, Stuhr LEB., Hyperbaric oxygen therapy and cancer–a review. Target Oncol. 2012;7(4):233–242.
8. Barja G., Updating the mitochondrial free radical theory of aging: an integrated view, key aspects, and confounding concepts. Antioxid Redox Signal. 2013;19(12):1420–1445.
9. Kim HS, Patel K, Muldoon-Jacobs K, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17(1):41–52.
10. Chen Y, Fu LL, Wen X, et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 2014;5:e1047.
11. Finley LWS, Carracedo A, Lee J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell. 2011;19(3):416–428.
12. Resseguie EA, Staversky RJ, Brookes PS, et al. Hyperoxia activates ATM independent from mitochondrial ROS and dysfunction. Redox Biol. 2015;5:176–185.
13. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
14. Igci M, Kalender ME, Borazan E, et al. High-throughput screening of sirtuin family of genes in breast cancer. Gene. 2016;586(1):123–128.
15. Papa L, Germain D., SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol. 2014;34(4):699–710.
16. +-dependent tubulin deacetylase. Mol Cell. 2003;11(2):437–444.
17. Šarić A, Crnolatac I, Bouillaud F, et al. Non-toxic fluorescent phosphonium probes to detect mitochondrial potential. Methods Appl Fluoresc. 2017;5(1):015007.
18. Sobočanec S, Balog T, Šarić A, et al. Cyp4a14 overexpression induced by hyperoxia in female CBA mice as a possible contributor of increased resistance to oxidative stress. Free Radic Res. 2010;44(2):181–190.
19. Venegas V, Wang J, Dimmock D, et al. Real-time quantitative PCR analysis of mitochondrial DNA content. Curr Protoc Hum Genet. 2011;Chapter(19):Unit 19.7.
20. R Development Core Team. R: A language and environment for statistical computing. Available from: http://www.R-project.org. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0; 2008.
21. Gonçalves AP, Máximo V, Lima J, et al. Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. Biochim Biophys Acta. 2011;1813(3):492–499.
22. Zheng JIE., Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol Lett. 2012;4(6):1151–1157.
23. Vander Heiden MG, Cantley LC, Thompson CB., Understanding the Warburg effect: the metabolic Requirements of cell proliferation. Science. 2009;324(5930):1029–1033.
24. Antico Arciuch VG, Elguero ME, Poderoso JJ, et al. Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Signal. 2012;16(10):1150–1180.
25. Liu CY, Lin HH, Tang MJ, et al. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget. 2015;6(18):15966–15983.
26. Childs BG, Baker DJ, Kirkland JL, et al. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15(11):1139–1153.
27. Shay JW, Roninson IB., Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene. 2004;23(16):2919–2933.
28. Murray-Zmijewski F, Slee EA, Lu X., A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol. 2008;9(9):702–712.
29. Burkhart DL, Sage J., Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008;8(9):671–682.
30. Liu ZJ, Velazquez OC., Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal. 2008;10(11):1869–1882.
31. Zabel DD, Feng JJ, Scheuenstuhl H, et al. Lactate stimulation of macrophage-derived angiogenic activity is associated with inhibition of poly(ADP-ribose) synthesis. Lab Invest. 1996;74(3):644–649.
32. Fernandez-Carrascal A, Garcia-Algar M, Nazarenus M, et al. Metabolic pathway for the universal fluorescent recognition of tumor cells. Oncotarget. 2017;8(44):76108–76115.
33. Moore RL, Faller DV., SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells. J Endocrinol. 2013;216(3):273–285.
34. Suski JM, Lebiedzinska M, Bonora M, et al. Relation between mitochondrial membrane potential and ROS Formation. In: Palmeira CM, Moreno AJ, eds. Mitochondrial bioenergetics: methods and protocols. Vol. 810. New York: Humana Press; 2012. p. 183–205.
35. Ziegler DV, Wiley CD, Velarde MC., Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging. Aging Cell. 2015;14(1):1–7.
36. Kagawa S, Gu J, Honda T, et al. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin Cancer. Res 2001;7(5):1474–1480.
37. Granowitz EV, Tonomura N, Benson RM, et al. Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation. Anticancer Res. 2005;25(6B):3833–3842.
38. Marinello PC, da Silva TNX, Panis C, et al. Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction. Tumour Biol. 2016;37(4):5337–5346.
39. Wiley CD, Velarde MC, Lecot P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 2016;23(2):303–314.